Effect of Different Manipulations on Serum Prostate-Specific Antigen (PSA) Level in Patients with Symptomatic Benign Prostatic Hyperplasia and Suspicion of Carcinoma Prostate

被引:0
|
作者
Ahmad, Ashfaq [1 ]
Iqbal, Muhammad [1 ]
Hassan, Sohail [2 ]
Jehan-Ur-Rehman, Shah [3 ]
Bashir, Ammar [4 ]
机构
[1] Social Secur Teaching Hosp Lahore, Urol, Lahore, Pakistan
[2] Social Secur Teaching Hosp Lahore, Lahore, Pakistan
[3] Lahore Gen Hosp, Urol, Lahore, Pakistan
[4] AFIU Rawalpindi, Urol, Rawalpindi, Pakistan
来源
PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES | 2019年 / 13卷 / 04期
关键词
Prostatic specific antigen; benign prostatic hyperplasia; Carcinoma prostate; DIGITAL RECTAL EXAMINATION; PROTEASE;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Prostate specific antigen is an organ specific marker. A temporary rise in prostate specific antigen serum level has been reported in various situations like, digital rectal examination, urethral catheterization, transurethral resection of prostate and transrectal ultrasound guided prostatic needle biopsy. Methodology: This comparative study is conducted at Department of Urology and Renal Transplantation Div, HQ. Teaching Hospital Mirpur Azad Kashmir from 1st June 2017 to 31st May 2018. Patients with symptomatic benign prostate hyperplasia and suspicion of carcinoma prostate on digital rectal examination with age above 50 years were included. All patients were divided into four groups. Group A comprised, patients who underwent digital rectal examination. Group B comprised, patients who underwent transurethral resection of prostate. Group C comprised, patients who underwent transurethral Foley catheterization due to retention of urine. Group D comprised, patients who underwent transrectal ultrasound guided prostatic needle biopsy for suspicion of ca prostate on digital rectal examination. Serum PSA was detected by enzyme linked immunosorbent serum assay (ELISA) method. Results: In group A pre manipulation mean serum PSA level was 1.22ng/ml, after 30 minutes it was 2.52ng/ml, where as after 72 hrs mean serum PSA level was 1.56ng/ml and after one week it dropped to 1.1ng/ml. In group B pre manipulation mean serum PSA level was 3.41ng/ml, after 30 minutes of manipulation it was 29.89ng/ml, after 72 hours and one week of manipulation it was 8.22ng/ml and 4.25ng/ml respectively and after 2 weeks it dropped to 3.78ng/ml. In group C pre manipulation mean serum PSA level was 2.81ng/ml, after 30 minutes it was 4.54ng/ml, where as after 72 hrs and 1 week of manipulation it was 3.76ng/ml and 2.40ng/ml respectively. In group D pre manipulation mean serum PSA level was 2.61ng/ml, after 30 minutes it was 4.53ng/ml, where as after 72 hrs and 1 week of manipulation it was 3.42ng/ml and 2.56ng/ml respectively. Conclusion: There is significant rise in serum prostate specific antigen after different manipulations except DRE.
引用
收藏
页码:840 / 843
页数:4
相关论文
共 50 条
  • [21] THE ROLE OF PROSTATE-SPECIFIC ANTIGEN IN THE EVALUATION OF BENIGN PROSTATIC HYPERPLASIA
    TCHETGEN, MB
    OESTERLING, JE
    UROLOGIC CLINICS OF NORTH AMERICA, 1995, 22 (02) : 333 - 344
  • [22] Detection of prostate cancer and changes in prostate-specific antigen (PSA) six months after surgery for benign prostatic hyperplasia in patients with elevated PSA
    Özden, C
    Inal, G
    Adsan, O
    Yazici, S
    Özturk, B
    UROLOGIA INTERNATIONALIS, 2003, 71 (02) : 150 - 153
  • [23] Impact of Treatment With Statins on Prostate-Specific Antigen and Prostate Volume in Patients With Benign Prostatic Hyperplasia
    Lee, Sang Hun
    Park, Tae Ju
    Bae, Min Ho
    Choi, Sung Ho
    Cho, Young Sam
    Joo, Kwan Joong
    Kwon, Chil Hun
    Park, Heung Jae
    KOREAN JOURNAL OF UROLOGY, 2013, 54 (11) : 750 - 755
  • [24] Relationship of prostate-specific antigen and prostate volume in patients with biopsy proven benign prostatic hyperplasia
    Hochberg, DA
    Armenakas, NA
    Fracchia, JA
    PROSTATE, 2000, 45 (04): : 315 - 319
  • [25] Effect of transurethral resection on serum free/total prostate-specific antigen levels in patients with benign prostatic hyperplasia
    Çetinkaya, M
    Ulusoy, E
    Aki, T
    Kosan, M
    Kundak, C
    Aydos, MM
    Gökkaya, S
    UROLOGY, 1999, 53 (01) : 118 - 120
  • [26] Changes in serum prostate-specific antigen following prostatectomy in patients with benign prostate hyperplasia
    Furuya, Y
    Akakura, K
    Tobe, T
    Ichikawa, T
    Igarashi, T
    Ito, H
    INTERNATIONAL JOURNAL OF UROLOGY, 2000, 7 (12) : 447 - 451
  • [27] IMPACT OF PROSTATE-SPECIFIC ANTIGEN DENSITY IN BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CARCINOMA - PRELIMINARY-RESULTS
    AKDAS, A
    DILLIOGLUGIL, O
    CEVIK, I
    ILKER, Y
    EUROPEAN UROLOGY, 1994, 25 (04) : 299 - 303
  • [28] INFLUENCE OF BENIGN PROSTATIC HYPERPLASIA, TESTOSTERONE AND AGE ON SERUM LEVELS OF PROSTATE-SPECIFIC ANTIGEN
    AUS, G
    BERGDAHL, S
    HUGOSSON, J
    LODDING, P
    NORLEN, L
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1994, 28 (04): : 379 - 384
  • [29] IMPACT OF PROSTATE-SPECIFIC ANTIGEN DENSITY IN BENIGN PROSTATIC HYPERPLASIA AND PROSTATE - EDITORIAL COMMENT
    OOSTERHOF, GON
    DEBRUYNE, F
    EUROPEAN UROLOGY, 1994, 25 (04) : 304 - 304
  • [30] Urinary prostate-specific antigen: predictor of benign prostatic hyperplasia progression?
    Pejcic, Tomislav P.
    Tulic, Cane Dz
    Lalic, Natasa V.
    Glisic, Biljana D.
    Ignjatovic, Svetlana D.
    Markovic, Biljana B.
    Hadzi-Djokic, Jovan B.
    CANADIAN JOURNAL OF UROLOGY, 2013, 20 (02) : 6707 - 6713